Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against The Chemours Company (“Chemours” or the...
-
The Schall Law Firm Encourages Investors in The Chemours Company with Losses to Contact the Firm
-
NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against The Chemours Company (“Chemours” or the...
-
The Schall Law Firm Encourages Investors in The Chemours Company with Losses to Contact the Firm
-
NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against The Chemours Company (“Chemours” or the...
-
The Schall Law Firm Encourages Investors in The Chemours Company with Losses to Contact the Firm
-
The Schall Law Firm Encourages Investors in The Chemours Company with Losses to Contact the Firm
-
NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against The Chemours Company (“Chemours” or the...
-
The Schall Law Firm Encourages Investors in The Chemours Company with Losses to Contact the Firm
-
Investors, who purchased shares of The Chemours Company (NYSE: CC), should contact the Shareholders Foundation in connection with pending Lawsuit.